Merger creates company with combined revenues of more than EUR 1.7bn
合并后,新公司年收入將超過(guò)17億歐元
Transaction expected to close in early March 2019
合并預計將于2019年3月初完成
Truly global footprint through comprehensive sales and distribution platform
真正實(shí)現銷(xiāo)售和分銷(xiāo)的全球化
Singapore and Lynge, Denmark – February 14, 2019: The European Commission has approved, under the EU Merger Regulation, the merger between Sivantos Pte. Ltd. (“Sivantos”), owned by EQT funds, and Widex A/S (“Widex”), owned by T&W Medical A/S.
新加坡和丹麥Lynge – 2019年2月14日:歐洲聯(lián)盟委員會(huì )批準了西萬(wàn)拓Sivantos(由EQT基金擁有)和唯聽(tīng)Widex A/S(由T&W醫療A/S公司擁有)兩家公司的合并提案。
Sivantos offers a diverse portfolio of technologically advanced hearing aid products across brands like Signia, Audio Service, Rexton and others. Widex’ portfolio of products includes a range of sophisticated hearing aid technology with a focus on the high-end segment.
西萬(wàn)拓Sivantos旗下?lián)碛性醋晕鏖T(mén)子聽(tīng)力的西嘉Signia、奧德聲Audio Service、力斯頓Rexton等品牌,提供先進(jìn)的助聽(tīng)器產(chǎn)品組合,唯聽(tīng)Widex產(chǎn)品組合包括一系列尖端助聽(tīng)器技術(shù),并主打高端助聽(tīng)器產(chǎn)品。
The Commission concluded the merger would raise no competition concerns. The merger has already been approved in all other relevant jurisdictions.
歐盟委員認為,兩家公司的合并不會(huì )導致同業(yè)競爭。合并已獲得兩公司所在司法管轄區的批準。
“Our goal at Widex has always been to develop the best possible hearing aids to improve the life of those with hearing needs. The merger with Sivantos brings us one step closer to that goal by building a company with one of the strongest research and development resources in the business and the sales channels to ensure our innovative products reach as many people as possible,” said Jan Tøpholm, Chairman of Widex A/S.
唯聽(tīng)Widex A/S公司董事長(cháng)Jan Tøpholm表示:“唯聽(tīng)Widex一直以科技研發(fā)為己任,并致力于改善聽(tīng)障人士的生活質(zhì)量?!?,“與西萬(wàn)拓集團的合并極大地擴展了雙方的業(yè)務(wù)資源和銷(xiāo)售渠道,讓我們離目標又進(jìn)了一步,從而讓我們的創(chuàng )新產(chǎn)品可以夠幫助更多的聽(tīng)障人士?!?/span>
“The merger between Widex and Sivantos is a transformative combination and unique opportunity to drive innovation through one of the most dynamic R&D teams in the industry to benefit the more than 700 million people with hearing needs,” said Marcus Brennecke, Global Co-Head of EQT Private Eq